Four Kennedy Appointees to U.S. Health Panel Allowed to Keep Drug Stocks

Four new members appointed by Kennedy to the U.S. Preventive Services Task Force have been granted waivers permitting them to retain financial interests in drug stocks. This decision raises concerns about potential conflicts of interest within the influential health advisory panel.

Originally published by nyt